129
Participants
Start Date
August 31, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
August 31, 2015
BIBW 2992
This is an open label study. Patients are treated with BIBW 2992 until disease progression or undue AEs
1200.22.28 Boehringer Ingelheim Investigational Site, Bakersfield
1200.22.32 Boehringer Ingelheim Investigational Site, Beverly Hills
1200.22.4 Boehringer Ingelheim Investigational Site, Mission Hills
1200.22.16 Boehringer Ingelheim Investigational Site, Orange
1200.22.19 Boehringer Ingelheim Investigational Site, Fort Lauderdale
1200.22.29 Boehringer Ingelheim Investigational Site, North Miami Beach
1200.22.10 Boehringer Ingelheim Investigational Site, Atlanta
1200.22.18 Boehringer Ingelheim Investigational Site, Chicago
1200.22.3 Boehringer Ingelheim Investigational Site, Bethesda
1200.22.14 Boehringer Ingelheim Investigational Site, Boston
1200.22.24 Boehringer Ingelheim Investigational Site, Flint
1200.22.5 Boehringer Ingelheim Investigational Site, Minneapolis
1200.22.15 Boehringer Ingelheim Investigational Site, New York
1200.22.26 Boehringer Ingelheim Investigational Site, New York
1200.22.1 Boehringer Ingelheim Investigational Site, Rochester
1200.22.27 Boehringer Ingelheim Investigational Site, Syracuse
1200.22.25 Boehringer Ingelheim Investigational Site, Valhalla
1200.22.6 Boehringer Ingelheim Investigational Site, Canton
1200.22.7 Boehringer Ingelheim Investigational Site, Wynnewood
1200.22.22 Boehringer Ingelheim Investigational Site, Mt. Pleasant
1200.22.31 Boehringer Ingelheim Investigational Site, Fairfax
1200.22.40 Boehringer Ingelheim Investigational Site, Renton
1200.22.33 Boehringer Ingelheim Investigational Site, Seattle
1200.22.88604 Taichung Veterans General Hospital, Taichung
1200.22.88605 China Medical University Hospital, Taichung
1200.22.88606 Boehringer Ingelheim Investigational Site, Tainan City
1200.22.88601 National Taiwan University Hospital, Taipei
1200.22.88602 Veterans General Hospital, Taipei
1200.22.88607 Boehringer Ingelheim Investigational Site, Taipei
1200.22.88603 Chang Gung Memorial Hosp-Linkou, Taoyuan District
Lead Sponsor
Boehringer Ingelheim
INDUSTRY